FDBTX | RDBTX | FDBTX / RDBTX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 8 years | 18 years | - |
Gain YTD | 10.084 | 9.748 | 103% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 250 | 400,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 5.13B | 5.13B | 100% |
Annual Yield % from dividends | 2.97 | 2.62 | 113% |
Returns for 1 year | 17.22 | 16.85 | 102% |
Returns for 3 years | 4.79 | 3.81 | 126% |
Returns for 5 years | 19.82 | 18.45 | 107% |
Returns for 10 years | N/A | 28.66 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
TIGRX | 16.26 | -0.05 | -0.28% |
Nuveen Core Equity R6 | |||
ETCHX | 33.18 | -0.16 | -0.48% |
Eventide Healthcare & Life Sciences C | |||
RPMFX | 16.96 | -0.09 | -0.53% |
Reinhart Genesis PMV Advisor | |||
KIRYX | 13.52 | -0.08 | -0.59% |
Westwood Global Rl Estt Inst | |||
MYITX | 8.07 | -0.05 | -0.62% |
NYLI WMC International Research Eq Cl A |